Market closed

Harvard Bioscience/HBIO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Harvard Bioscience

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Ticker

HBIO
Trading on

Industry

Life Sciences Tools & Services

Employees

404

HBIO Metrics

BasicAdvanced
$110M
Market cap
-
P/E ratio
-$0.25
EPS
1.31
Beta
-
Dividend rate
$110M
1.31
$5.56
$2.32
115K
2.053
0.731
54.535
61.64
-1.11%
-1.62%
-14.97%
1.077
1.64
-39.11
17.93
-11.36%
93.45%
-3.12%
52.41%

What the Analysts think about HBIO

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Harvard Bioscience stock.

HBIO Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

HBIO Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy HBIO

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Harvard Bioscience stock?

Harvard Bioscience (HBIO) has a market cap of $110M as of October 13, 2024.

What is the P/E ratio for Harvard Bioscience stock?

The price to earnings (P/E) ratio for Harvard Bioscience (HBIO) stock is 0 as of October 13, 2024.

Does Harvard Bioscience stock pay dividends?

No, Harvard Bioscience (HBIO) stock does not pay dividends to its shareholders as of October 13, 2024.

When is the next Harvard Bioscience dividend payment date?

Harvard Bioscience (HBIO) stock does not pay dividends to its shareholders.

What is the beta indicator for Harvard Bioscience?

Harvard Bioscience (HBIO) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.